Skip to main content

Table 2 Mean scores of scales from the Short Form (SF-36) and the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Core Questionnaire (QLQ-C30) 12 months after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS + HIPEC). Presented as the mean values with standard deviations. The mean difference between patients with and without an incisional hernia is presented with 95% confidence interval

From: Incisional hernia and its impact on health-related quality of life after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a national prospective cohort study

  Patients with incisional hernia (n = 9) Patients without incisional hernia (n = 64) Mean difference
SF-36
 Physical functioning 82.2 (16.0) 86.4 (17.6) − 4.2 (− 16.6; 8.2)
 Role-physical 38.9 (43.5) 71.8 (38.2)* − 32.9 (− 60.6; − 5.3)
 Bodily pain 81.7 (24.0) 81.1 (22.7) 0.6 (− 15.6;16.8)
 Social functioning 91.7 (14.0) 87.9 (21.5) 3.8 (− 11.0; 18.5)
 Role-emotional 61.1 (35.4) 81.3 (32.2) − 20.2 (− 43.4; 3.1)
EORTC QLQ-C30
 Global health 85.2 (13.0) 77.1 (19.7)* 8.1 (− 5.5; 21.6)
 Role functioning 79.6 (21.7) 80.2 (28.8) − 0.6 (− 20.5; 19.3)
 Emotional functioning 98.2 (5.6) 83.8 (15.2)* 14.4 (4.1; 24.6)
 Social functioning 90.7 (16.9) 90.5 (19.8)* 0.2 (− 13.6; 14.1)
 Fatigue 29.6 (24.8) 27.1 (24.4) 2.5 (− 14.8; 19.9)
 Nausea and vomiting 11.1 (22.0) 3.4 (9.9) 7.7 (− 0.7; 16.2)
 Pain 13.0 (20.0) 16.2 (20.1) − 3.2 (− 17.5; 11.1)
 Constipation 7.4 (22.2) 6.9 (14.9)* 0.5 (− 10.8; 11.8)
 Diarrhea 22.2 (37.3) 19.1 (29.2)* − 3.1 (− 18.3; 24.6)
  1. *n = 63 patients